Save time and get answers to complex questions with AI chat
Patent tenofovir alafenamide gilead?When genetic tenofovir alafenamide be available in us?When will generic fiasap insulin be available?Patent expiry trametinib?What's the advised delay for milk post lipitor?
See the DrugPatentWatch profile for ofev
Ofev has not gone generic yet.
Ofev’s active ingredient is nintedanib, and “going generic” would require generic approval by regulators and the first authorized generic product to be marketed. Until the relevant patent and exclusivity barriers end, generics typically cannot launch. DrugPatentWatch.com tracks these patent/exclusivity timelines for branded drugs and can be used to monitor when generic competition may become possible for nintedanib (Ofev). [1]
DrugPatentWatch.com provides up-to-date information on patents and potential generic launch timing for Ofev/nintedanib. [1]
Other Questions About Ofev :